Wenjuan Zheng - Concepedia

Author

Wenjuan Zheng

Jiangsu Province Hospital ORCID

Also Known As

Wen-Juan Zheng, Wen-juan Zheng, Wenjuan Zheng, Zheng Wenjuan

Publications

978

Citations

H-Index

Concepts

All Affiliations

Jiangsu Province Hospital Tongji University Nanchang University Nanjing Medical University Zhejiang Cancer Hospital

About

Wenjuan Zheng is an author at Jiangsu Province Hospital specializing in medicine, lung cancer, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	232
2	Business	1	1	11
3	Health Sciences	1	1	76
4	Social Sciences	1	1	11
5	Economics	1	1	11

Wenjuan Zheng

Publications

845

Citations

H-Index

Page 1

	Year	Citations
BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non–Small-Cell Lung Cancer Caicun Zhou, Yi‐Long Wu, Gongyan Chen, Journal of Clinical Oncology	2015	381
Tislelizumab Plus Platinum and Etoposide Versus Placebo Plus Platinum and Etoposide as First-Line Treatment for Extensive-Stage SCLC (RATIONALE-312): A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase 3 Clinical Trial Ying Cheng, Yun Fan, Yanqiu Zhao, Journal of Thoracic Oncology Phase 3Clinical TherapeuticPharmacologyClinical TrialsFirst-line Treatment	2024	104
Tislelizumab Versus Docetaxel in Patients With Previously Treated Advanced NSCLC (RATIONALE-303): A Phase 3, Open-Label, Randomized Controlled Trial Caicun Zhou, Dingzhi Huang, Yun Fan, Journal of Thoracic Oncology	2022	97
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial Dongsheng Yue, Wenxiang Wang, Hongxu Liu, The Lancet Respiratory Medicine Interim AnalysisSurgical OncologyNeoadjuvant ChemotherapyMedicineMetronomic Therapy	2024	76
Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia Lijuan Chen, Yaping Zhang, Wenjuan Zheng, Leukemia Research Hematological MalignancyLymphoid NeoplasiaChronic Lymphocytic LeukemiaMedicineGenetics	2008	52
Overexpressed targeting protein for Xklp2 (TPX2) serves as a promising prognostic marker and therapeutic target for gastric cancer Bo Liang, Wenjuan Zheng, Fang Lü, Cancer Biology & Therapy	2016	46
Decreased Expression of Programmed Death Ligand-L1 by Seven in Absentia Homolog 2 in Cholangiocarcinoma Enhances T-Cell–Mediated Antitumor Activity Hao Zheng, Wenjuan Zheng, Zhenguang Wang, Frontiers in Immunology	2022	37
Effectiveness of enteral feeding protocol on clinical outcomes in critically ill patients: A before and after study Qian Li, Zhongheng Zhang, Bo Xie, PLoS ONE	2017	28
The prognostic evaluation of CLLU1 expression levels in 50 Chinese patients with chronic lymphocytic leukemia Lijuan Chen, Jianyong Li, Wenjuan Zheng, Leukemia & lymphoma/Leukemia and lymphoma	2007	13
Estimating the Preservation Value of Wuyishan National Park from the Perspective of Bounded Rational Decision Making Chang Liu, Mingshui Lin, Xinhua Qi, Sustainability Natural Resource ValuationLand UseSustainable DevelopmentValue TheoryEnvironmental Economics	2021	11

Page 1